AHT vs FTHM

The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 2/9, indicating severe operational and profitability concerns. Despite a positive current and quick ratio, the company exhibits negative profitability across multiple metrics including a -20.97% profit margin and a negative Price/Book ratio, signaling deep balance sheet distress. The stock has lost nearly all value over the past five years (-98.5%), and while recent quarters show volatile earnings surprises, the long-term trend remains downward with negative revenue growth and no analyst coverage. Absence of Altman Z-Score and Graham Number further underscores data unreliability and lack of defensive investment appeal.

FTHM exhibits critical financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total failure across all fundamental health benchmarks. The company suffers from chronic profitability issues, with a -49.46% ROE and a consistent track record of missing earnings estimates over the last 23 quarters. Despite trading at a low Price/Book (0.75) and Price/Sales (0.07), these metrics appear to be a value trap given the negative revenue growth and catastrophic 5-year price decline of 97.4%. The single analyst's 'strong buy' recommendation is heavily contradicted by the deterministic data.